Key result
Physiological pacing is discussed as a technological innovation for bradycardia, though its widespread adoption is hindered by high costs and initial complication rates.
An editorial discussing the technological, clinical, and economic challenges associated with the adoption of physiological pacing.
Perhaps because cardiac pacing stands at the frontiers between cardiology, electronics, and surgery, con- troversy has invariably arisen with the appearance of each technological innovation.Now another advance, "physiological" pacing, has passed through its initial trial period and stands at the crossroads.Lack of confidence in the reliability of new technology, high initial complication rates, and high costs militate against the immediate and widespread use of new forms of pacing.These concerns have quite understandably led those involved in pacemaker implantation to question the real need for each inno- vation.Now that the pacing fraternity is confronted (in reality for the second time') with yet another development, it is appropriate to examine the relation between it and the factors that previously retarded progress, in the hope that a speedier resolution may be obtained.The term "physiological pacing" has the merit of brevity and little else.Any form of cardiac pacing is more physiological than the bradycardia it is intended to correct, at least when the mechanism is atrioven-
No takes yet. Share an insight, caveat, or question.
J S Geddes (1983) conducted an editorial in Bradycardia. Physiological pacing was evaluated. Physiological pacing is discussed as a technological innovation for bradycardia, though its widespread adoption is hindered by high costs and initial complication rates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: